Gästeforum » and approval procedur

Chinese Clinical Imported and Overseas New Drugs - Guidebook for Review and Approval Procedures

Chinas 1.3 billion has been routed as the second largest economy in the global domain Barry Larkin Jersey , with an increase in the dominance of the global economy. The country has been one of the largest in contributing to the worldwide growth in the financial crisis of 2008.


China is one of the fastest growing global economies with a one-fifth population in the world. Nowadays, China has become the worlds second largest healthcare market after the United States. Facing a gigantic population and rapid population aging Chris Sabo Jersey , the Chinese government accelerated the priority approval of innovative drugs and relaxed the market access for overseas drugs to cope with the clinical urgent demand. In recent years, China鈥檚 fast-track approval time is much shorter than any other country Reggie Sanders Jersey , which attracts more and more overseas pharmaceutical manufacturers to enter into the Chinese healthcare market.


Undoubtedly the Chinese healthcare market of nearly 1.4 billion populations is a huge business opportunity for the overseas pharmaceutical manufacturers.


The Chinese 鈥淣ational Medical Products Administration (NMPA)鈥?and the 鈥淣ational Health Commission (NHC)鈥?jointly issued the latest 鈥淩eview and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand鈥?on October 23, 2018 Anthony DeSclafani Jersey , which provided a dedicated pathway for priority review and approval of overseas drugs importing to Chinese healthcare market and clarified the specific review and approval procedures.


Market Analysis:
To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of the Chinese healthcare market, how do the foreign pharmaceutical manufacturers in compliance with the latest 鈥淩eview and Approval Procedures of Overseas Imported New Drugs for Clinical Urgent Demand鈥? How do the overseas pharmaceutical manufacturers operate business smoothly in China? The overseas and multinational pharmaceutical manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the latest regulations for priority review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand. The Chinese regulatory approach is unique.


The Latest Guidebook for Review and Approval Procedures of Overseas Imported New Drugs for Chinese Clinical Urgent Demand (2019 Edition) is an essential resource for overseas and multinational pharmaceutical manufacturers to successfully acquire the marketing authorization in China Brandon Finnegan Jersey , which provided a detailed guidance for comprehensive knowledge of the latest regulations on review and approval procedures of overseas imported new drugs for Chinese clinical urgent demand to navigate regulatory requirements step by step.


This guidebook is organized as follows:
Provides the latest description of the Chinese changing healthcare market landscape and rapidly changing regulatory framework as a background for the audience.
Introduces that review and approval procedures of overseas imported new drugs of Chinese clinical urgent demand are applicable to what scope of drug varieties.
Expounds the selection process of drug varieties.


Elaborates the details of the review and approval procedures of overseas imported new drugs of Chinese clinical urgent demand.


Expounds the Chinese drug regulatory authoritys requirements for application materials that overseas applicants apply for overseas imported new drugs of Chinese clinical urgent demand.


Expounds the duties and obligations of overseas pharmaceutical manufacturers for drugs exported to the Chinese healthcare market.


Elaborates the Chinese drug regulatory authoritys latest 鈥淎dministrative Measures for Communication and Exchange on Drug Research and Development and Technical Review and Approval鈥?to guide the overseas applicants to take the key first step entry into the dedicated pathway of priority review and approval procedures and to smoothly pass the review and approval procedures.


Exhibits the first batch list of overseas imported new drugs of Chinese clinical urgent demand that has been selected by the Chinese drug regulatory authority, which is calling the overseas applicants to submit the application for marketing in China to the Chinese drug regulatory authority Ken Griffey Jersey , also let the overseas pharmaceutical manufacturers understand the Chinese drug regulatory authority鈥檚 distinctive regulatory current status.